| Identification | Back Directory | [Name]
LRRK2-kinase inhibitor | [CAS]
1285515-21-0 | [Synonyms]
CS-1790
GSK2578215
SK2578215A
GSK2578215A
GSK2578125A
GSK2578215A, >=98%
LRRK2-kinase inhibitor
GSK2578215A >=98% (HPLC)
LRRK2 inhibitor GS2578215A
LRRK2 inhibitor GSK2578215A
LRRK2-kinase inhibitor USP/EP/BP
5-(2-Fluoropyridin-4-yl)-2-phenylmethoxy-N-pyridin-3-ylbenzamide
2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzaMide
5-(2-Fluoro-4-pyridinyl)-2-(phenylmethoxy)-N-3-pyridinylbenzamide
BenzaMide, 5-(2-fluoro-4-pyridinyl)-2-(phenylMethoxy)-N-3-pyridinyl-
5-(2-fluoro-4-pyridinyl)-2-[(phenylmethyl)oxy]-N-3-pyridinylbenzamide
5-(2-Fluoro-4-pyridinyl)-2-(phenylmethoxy)-N-3-pyridinylbenzamide GSK2578215A | [Molecular Formula]
C24H18FN3O2 | [MDL Number]
MFCD22665702 | [MOL File]
1285515-21-0.mol | [Molecular Weight]
399.417 |
| Chemical Properties | Back Directory | [Boiling point ]
556.1±50.0 °C(Predicted) | [density ]
1.292±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO: soluble15mg/mL, clear | [form ]
powder | [pka]
12.31±0.70(Predicted) | [color ]
white to beige |
| Hazard Information | Back Directory | [Uses]
GSK2578215A is a potent, selective LRRK2 inhibitor and a promising therapeutic for treating Parkinson''s disease. | [storage]
Store at RT |
|
|